Pricing
Prices are indicative MRP and may vary by pharmacy. Trend compares against the last recorded price.
All price changes →Aclitol
Rx400 mcg+12 mcg • Dry Powder Inhalation Capsule (DPI)
Indications & Uses
It is indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).
Dosage Reference
Reference Information Only
Dosages shown are general references from official sources. Always consult your doctor or pharmacist for personalized dosing.
Adults:
For oral inhalation only. Should be taken by inhaler device. 400 mcg/12 meg, twice daily (One inhalation capsule in the morning and one in the evening ). Do not take more than one inhalation twice daily.
Side Effects
Most common adverse reactions (incidence 3% and more common than with placebo) include: upper respiratory tract infection and headache.
Cautions & Contraindications
Warnings & Precautions
Asthma-related death: Long-acting beta2-adrenergic agonists as monotherapy (without an inhaled corticosteroid) for asthma increase the risk of serious asthma-related events. Do not initiate in acutely deteriorating COPD or to treat acute symptoms. Do not use in combination with additional medicine containing a LABA because of risk of overdose. If paradoxical bronchospasm occurs, discontinue Aclitol and institute alternative therapy. Use with caution in patients with convulsive disorders, thyrotoxicosis, diabetes mellitus and ketoacidosis. Be alert to hypokalemia and hyperglycemia. Use with caution in patients with narrow-angle glaucoma and instruct patients to contact a physician immediately if symptoms occur. Worsening urinary retention may occur. Use with caution in patients with prostatic hyperplasia or bladder-neck obstruction and instruct patients to consult a physician immediately if symptoms occur.
Contraindications
Use of a long-acting beta 2-adrenergic agonist (LABA), including formoterol fumarate, one of the active ingredients in this combination, without an inhaled corticosteroid is contraindicated in patients with asthma. Hypersensitivity to aclidinium bromide or formoterol fumarate or to any component of this product.